SCHEMBL4902665

SCHEMBL4902665

CCN(c1ccc(NC(=O)c2ccc3ccccc3c2)cc1)S(=O)(=O)c1ccc(C)c(C(=O)OC)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 2/20 0.50
PLAU P00749 2/20 0.49
NPC1 O15118 1/20 0.48
CASP3 P42574 1/20 0.48
RAB9A P51151 1/20 0.48
SENP7 Q9BQF6 1/20 0.48
LMNA P02545 7/20 0.48
ALDH1A1 P00352 2/20 0.48
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
MAPT P10636 9/20 0.47
GPR27 Q9NS67 1/20 0.47
ENPP1 P22413 3/20 0.46
ENPP3 O14638 2/20 0.46
HTT P42858 2/20 0.46
TP53 P04637 1/20 0.46
HPGD P15428 1/20 0.46
NCOA3 Q9Y6Q9 1/20 0.46
THRB P10828 1/20 0.46
MAPK1 P28482 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4906199 0.91 LMNA (0.51) ENPP2LMNAALDH1A1MEN1KMT2A
SCHEMBL4905784 0.87 LMNA (0.47) NPC1RAB9ALMNAALDH1A1MEN1
SCHEMBL4907631 0.85 LMNA (0.55) LMNAALDH1A1MEN1KMT2AMAPT
SCHEMBL4905920 0.85 HDAC8 (0.54) ENPP2RAB9ALMNAALDH1A1MEN1
SCHEMBL4902866 0.84 HDAC8 (0.56) LMNAMAPTHTTSMN1; SMN2NPSR1
SCHEMBL4903818 0.80 ESR1 (0.52) LMNAALDH1A1MAPTSMN1; SMN2
SCHEMBL4902660 0.79 PRMT1 (0.54) ENPP2PLAUNPC1CASP3RAB9A
SCHEMBL4902733 0.78 ESR1 (0.60) LMNAALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL4906350 0.78 LMNA (0.55) LMNAALDH1A1MEN1KMT2AMAPT
SCHEMBL4897517 0.77 ALDH1A1 (0.49) LMNAALDH1A1MAPTHTTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD ENPP2 1811/4885PLAU 3550/4885NPC1 50/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD ENPP2 1582/4885PLAU 3190/4885NPC1 59/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD ENPP2 1582/4885PLAU 3190/4885NPC1 59/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.